Mohammad AskarPublic working copy · medical review pending

Noninfectious choroiditis · 055

Choroiditis: locate inflammation and exclude infection

Multimodal imaging connects the lesion pattern with its clinical course; a white spot alone does not define mechanism.

Public working copy · medical review pending. Source, translation and medical checks remain open. Read the limitations in the text and references. These educational materials do not replace individual medical assessment. Published: 2026-11-18T19:45:52+01:00. Internal project references lead to this notice. They are not publicly accessible primary sources; the source limitations remain stated in the text.

Use phenotype, imaging, infection assessment and visual threat together before treatment.

Terminology and draft status

Terminology review is not complete. Selected actual WHO UMD queries and their limits are recorded in terminology.md; they do not approve the whole translation.

01Appearance and mechanism

White dot syndromes (WDS) remains a recognised descriptive umbrella for heterogeneous posterior inflammatory disorders, not a single pathological process. The original demand to abolish it as obsolete is the Herbort/Farrag teaching perspective; an imaging-based split into choriocapillaritis and stromal choroiditis is useful but does not establish universal agreement or justify deleting established terms. 1 2 3

The 1995 perspective Fundal white dots: the spectrum of a similar pathological process is documented in the 2021 review, but its original full text and the claimed 26-entity list, including Behçet disease, were not inspected here. Sympathetic ophthalmia, APMPPE and parasitic DUSN illustrate why similar fundus colour does not imply the same cause. Myelinated nerve fibres, cotton-wool spots, drusen and herpetic lesions also need their own differential diagnosis. 1 2

02Read complementary images

ICGA uses indocyanine green fluorescence near 830 nm, penetrating the pigment epithelium better than visible fluorescein. The source describes up to 98% protein binding and a macromolecular complex passing from fenestrated choriocapillaris into stroma; these are mechanistic teaching values, not a fixed binding fraction in every setting. Geographic hypofluorescence suggests impaired perfusion; round hypofluorescent dark dots (HDDs) suggest stromal foci. Neither proves histological granulomas by itself. 1 2

The jellyfish analogy describes choriocapillaris lesions hidden immediately beneath RPE; the iceberg analogy describes more extensive hidden stromal foci. B-scan still supplies useful morphology. FA evaluates retinal vascular leakage, disc and some choroidal perfusion effects; it is complementary, not useless for posterior uveitis. SD-OCT shows outer-retinal consequences and EDI-OCT choroidal depth and thickness, which vary with stage and technique. 1 2

OCTA detects motion above flow and signal thresholds; an apparent flow void may reflect slow flow, segmentation or artefact. Normal-looking OCTA does not exclude MEWDS, and its pathogenesis remains debated rather than proving either primary photoreceptoritis or distal nonperfusion. BL-FAF reflects fluorophore distribution and masking or unmasking as well as tissue damage; correlate with OCT and angiography instead of equating every bright area with one mechanism. 1 2 4

Read complementary images
MethodWhat it showsLimit
ICGAChoroidal perfusion and stromal patternsHypofluorescence is not specific histology
SD-OCTOuter segments, RPE and structural consequencesStructure alone does not establish cause
EDI-OCTChoroidal thickness, often acute thickening and chronic thinningStage and sampling matter; not invariably less sensitive
OCTAFlow-dependent vascular signalSlow flow and artefacts; normal image does not exclude MEWDS
BL-FAFFluorophores and masking effects in affected tissueCorrelate with OCT and angiography

03Choriocapillaris phenotypes

In the source framework, MEWDS lies at the usually mild reversible end and APMPPE/AMIC between this and recurrent destructive MFC or SC. Location and severity help interpret evolution, but they are not histologically proven vascular levels in every patient. MEWDS is often unilateral and self-limiting with outer-retinal and autofluorescence changes; rare CNV is possible. AZOOR is a separate outer-retinal disorder, not interchangeable with MEWDS. 1 2 4

APMPPE is often bilateral; the Deutman 1972 AMIC interpretation is described in the later review, not independently read in its original report. MFC and PIC overlap clinically, commonly in young myopic women, with recurrence and CNV risk; neither a negative histoplasma test nor a similar scar proves all presumed ocular histoplasmosis syndrome (POHS) is MFC. Treatment follows active lesions, CNV and threat, not the umbrella name alone. 1 2

SC can expand with irreversible scarring and may need intensive combined immunosuppression, but triple therapy is not mandatory for every case. Exclude infectious serpiginous-like disease before immunosuppression: a negative IGRA cannot by itself exclude tuberculosis and a positive result does not alone prove ocular causation. Ampiginous and relentless placoid chorioretinitis can combine phenotypes and require close follow-up. ASPPC requires anti-syphilitic treatment; TB-associated disease needs specialist antimicrobial treatment with adjunct anti-inflammatory therapy when indicated. 1 2 5 7

Choriocapillaris phenotypes
EntityProposed level in source modelCourseNext consideration
MEWDSDistal choriocapillaris, debatedOften mild, unilateral, reversibleOCT/FAF, rare CNV; distinguish AZOOR
APMPPE/AMICPrecapillary involvement proposedOften bilateral, variable severityAssess visual and neurological threat
MFC/PIC/POHS differentialVariable choriocapillary disease; not all identicalRecurrences and CNV, often myopic womenConfirm phenotype; treat activity and CNV
SCMore proximal arterioles proposedProgressive scarring possibleExclude infectious mimic; individual immunosuppression

04Stromal disease and systemic context

Vogt–Koyanagi–Harada disease (VKH) is an immune-mediated stromal choroiditis associated with melanocyte antigens and may produce exudative retinal detachment. Distinguish initial-onset from chronic disease when assessing imaging, response and prognosis. Sympathetic ophthalmia (SO) follows ocular trauma or surgery; multiple operations are not required. Their resemblance does not erase the different history. 1 2

Birdshot retinochoroiditis (BRC) strongly associates with HLA-A29 and affects choroid and retinal vessels; visible cream-coloured lesions may appear later. HLA-A29 and both visible lesions and vasculitis are not mandatory in every published classification pathway. SUN criteria are research classification, not a substitute for individual diagnosis. Sarcoidosis can involve retina and choroid with variably distributed HDDs; calling the choroid an innocent bystander is an explanatory metaphor, not proof of mechanism in an individual. 1 2 6

Stromal disease and systemic context
EntityContextImaging and limit
VKHMelanocyte-associated immune inflammationDiffuse stromal disease, acute exudative detachment; distinguish chronic phase
SOAfter trauma or surgeryVKH-like inflammation; multiple operations not required
HLA-A29 BRCStrong genetic association, choroid and retinal vesselsICGA may precede visible lesions; classification pathways differ

05Clinical sequence and targeted tests

Begin with site, time course and visual threat, examine both eyes and reconsider the history when the pattern changes. A respectful repeated sexual or infection history can be essential. Record meaningful negatives such as no hypopyon or retinitis. Red-free imaging and gonioscopy are useful when indicated, not compulsory for every posterior lesion. Consider lymphoma or another masquerade at any age when the course is atypical. 1

Select blood count, renal and liver tests, ESR/CRP, syphilis testing, chest imaging, ACE and TB assessment from the clinical question and before relevant systemic treatment. ACE can be affected by ACE inhibitors and is not a diagnostic verdict. Isolated laboratory results do not replace the phenotype. Topical treatment alone usually cannot treat sight-threatening posterior disease; choose cause-specific therapy and monitor efficacy and systemic toxicity. Central location increases urgency but does not by itself dictate aggressive immunosuppression. 1

06Use the comparison in context

The comparison table is a clinical orientation within the source framework, not a diagnostic algorithm validated against all mimics. Follow symptoms, acuity, fields and the relevant imaging over time; scars, active inflammation and CNV require different responses. Preserve alternative classifications and uncertain source attributions explicitly. 1

Use the comparison in context
EntityFramework compartmentTypical ICGA patternClinical feature and limit
MEWDSChoriocapillaris hypothesisPatchy hypofluorescenceOften transient; mechanism debated
APMPPEChoriocapillaryGeographic hypofluorescenceBilateral placoid lesions; severity varies
MFCChoriocapillary frameworkMultifocal lesions, including occult activityScars and CNV; no automatic POHS equivalence
SCChoriocapillary frameworkConfluent geographic nonperfusion patternProgression; assess TB mimic
ASPPCSecondary infectious associationPlacoid hypofluorescenceSyphilis requires antimicrobial therapy
VKHPrimary stromal frameworkNumerous relatively regular HDDsAcute versus chronic disease
BRCStroma with retinal diseaseHDDs may precede visible spotsHLA-A29 association; retinal vasculitis assessment
SarcoidosisSecondary systemic associationVariably sized and distributed HDDsRetinal and systemic assessment; not specific alone
What are the main learning points?

Use phenotype, imaging, infection assessment and visual threat together before treatment.

When is assessment urgent?

New visual loss, a field defect or severe headache with posterior inflammation requires prompt specialist assessment.

References and access status

  1. 1
    Immutable original export; Herbort/Farrag attribution, unverified lecture recording

    Complete export read; original attribution and any recording/transcript or appointment not independently verified.

  2. 2
    Herbort et al 2021: Clinicopathology of non-infectious choroiditis

    Main article sections from introduction through concluding comments and abbreviations read via official NCBI BioC XML; figures as text/captions only, original historical reports and supplements unread. This is a perspective framework, not proof of consensus.

  3. 3
    NLM MeSH: White Dot Syndromes

    Actual indexed definition and entry terms read; terminology record, not therapeutic guidance.

  4. 4
    Papasavvas et al: MEWDS alternative perspective

    Selected indexed criteria/abstract read on 2026-11-09; direct PMC full-text access returned a browser challenge; no complete report appraisal claimed.

  5. 5
    SUN: Classification Criteria for Serpiginous Choroiditis

    Selected indexed criteria/abstract read on 2026-11-09; direct PMC full-text access returned a browser challenge; no complete report appraisal claimed.

  6. 6
    SUN: Classification Criteria for Birdshot Chorioretinitis

    Selected indexed criteria/abstract read on 2026-11-09; direct PMC full-text access returned a browser challenge; no complete report appraisal claimed.

  7. 7
    CDC 2025: clinical and laboratory diagnosis of tuberculosis

    Actual indexed interpretation-of-test-results section read: negative immune testing does not exclude disease.

Original lecture link